Status:
SUSPENDED
Adenosine Receptors Influence Ischemia-Reperfusion Injury
Lead Sponsor:
Radboud University Medical Center
Conditions:
Ischemia-Reperfusion Injury
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Ischemic preconditioning is defined as the development of tolerance to ischemia-reperfusion injury by a previous short bout of ischemia resulting in a marked reduction in infarct size. This mechanism ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy volunteers
Exclusion
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00184847
Start Date
March 1 2005
Last Update
March 28 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud University Nijmegen Medical Centre/Department of Pharmacology and Toxicology
Nijmegen, Gelderland, Netherlands, 6500 HB